PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease

Parkinson’s disease (PD) is characterized mainly by the loss of dopaminergic neurons in the substantia nigra (SN) mediated via oxidative stress. Although glutaredoxin-1 (GLRX1) is known as one of the antioxidants involved in cell survival, the effects of GLRX1 on PD are still unclear. In this study,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Molecules
Main Authors: Choi, Yeon Joo, Kim, Dae Won, Shin, Min Jea, Yeo, Hyeon Ji, Yeo, Eun Ji, Lee, Lee Re, Song, Yejin, Kim, Duk-Soo, Han, Kyu Hyung, Park, Jinseu, Lee, Keun Wook, Park, Jong Kook, Eum, Won Sik, Choi, Soo Young
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8198499/
https://ncbi.nlm.nih.gov/pubmed/34206041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26113329
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados